[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

IE34583L - Esters of hydroxyphenylalkanolamines - Google Patents

Esters of hydroxyphenylalkanolamines

Info

Publication number
IE34583L
IE34583L IE700394A IE39470A IE34583L IE 34583 L IE34583 L IE 34583L IE 700394 A IE700394 A IE 700394A IE 39470 A IE39470 A IE 39470A IE 34583 L IE34583 L IE 34583L
Authority
IE
Ireland
Prior art keywords
carbon atoms
cycloalkyl
alkyl
hydrogen
formula
Prior art date
Application number
IE700394A
Other versions
IE34583B1 (en
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Priority to IE131/73A priority Critical patent/IE34584B1/en
Publication of IE34583L publication Critical patent/IE34583L/en
Publication of IE34583B1 publication Critical patent/IE34583B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyridine Compounds (AREA)

Abstract

1298771 Sympathomimetic medicines STERLING DRUG Inc 20 March 1970 [1 April 1969] 13690/70 Heading A5B [Also in Division C2] Pharmaceutical compositions having sympathomimetic effects particularly bronchodilator activity being in conventional forms for oral or parenteral administration or in the preferred form as an aerosol inhalant preparation comprise an amino-ester of formulae I or II wherein R is hydrogen (only in formula II), alkyl having 1-4 carbon atoms, or cycloalkyl having 3-6 carbon atoms; R<SP>1</SP> is hydrogen or alkyl having 1-3 carbon atoms; Y is an acyl member which is alkanoyl having 1-22 carbon atoms, alkenoyl having one or two double bonds and having 4-22 carbon atoms, O # cycloalkyl -C n H 2n -C- having a total of 4-10 carbon atoms of which 3-7 are ring carbon atoms in cycloalkyl and wherein n is zero, one, or two, phenoxyacetyl, naphthalenecarbonyl, pyridinecarbonyl, phenyl -C n H 2n O # -C- wherein n is zero, one or two and phenyl is unsubstituted or is substituted by 1-3 alkyl having 1-4 carbon atoms, alkoxy having 1-4 carbon atoms, halo, trifluoromethyl, dialkylamino having 2-8 carbon atoms, or alkanoylamine having 1-6 carbon atom groups; and Y<SP>1</SP> and Y<SP>2</SP> are the same or different and are hydrogen or one of the acyl members defined by Y, and wherein in Formula I at least one of Y and Y<SP>1</SP> contains no less than four carbon atoms when R is tert-butyl or cycloalkyl and no less than seven carbon atoms when R is alkyl other than tertbutyl, and in Formula II at least one of Y and Y<SP>1</SP> contains no less than four carbon atoms; or an acid-addition salt thereof and a suitable conventional carrier, and if necessary, a propellant. [GB1298771A]
IE394/70A 1969-04-01 1970-04-01 Carboxylic esters of hydroxyphenylalkanolamines IE34583B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IE131/73A IE34584B1 (en) 1969-04-01 1970-04-01 Esters of alpha-aminomethyl-3-(hydroxy or hydroxymethyl)-4-hydroxyphenyl ketones

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81237069A 1969-04-01 1969-04-01

Publications (2)

Publication Number Publication Date
IE34583L true IE34583L (en) 1970-10-01
IE34583B1 IE34583B1 (en) 1975-06-25

Family

ID=25209368

Family Applications (1)

Application Number Title Priority Date Filing Date
IE394/70A IE34583B1 (en) 1969-04-01 1970-04-01 Carboxylic esters of hydroxyphenylalkanolamines

Country Status (17)

Country Link
JP (2) JPS5314544B1 (en)
AT (1) AT300762B (en)
BE (1) BE748178A (en)
CH (1) CH522589A (en)
DE (1) DE2015573C3 (en)
DK (1) DK131459B (en)
ES (1) ES378092A1 (en)
FI (1) FI54796C (en)
FR (1) FR2042295B1 (en)
GB (1) GB1298771A (en)
IE (1) IE34583B1 (en)
IL (2) IL34148A (en)
NL (1) NL171155C (en)
NO (1) NO129903B (en)
PH (2) PH9407A (en)
SE (2) SE381039B (en)
ZA (1) ZA702065B (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4138581A (en) 1969-04-01 1979-02-06 Sterling Drugs Inc. 3(Hydroxy or hydroxymethyl)-4(hydroxy)-α-(aminomethyl)benzyl alcohols
US3809714A (en) * 1972-08-31 1974-05-07 Interx Research Corp Novel ester of ((methylamino)methyl) benzyl alcohol
US3868461A (en) * 1972-11-22 1975-02-25 Interx Research Corp Ester of 3,4-dihydroxy-alpha (isopropylamino) methyl benzyl alcohol, composition and anti-asthma use thereof
US4046913A (en) 1973-08-18 1977-09-06 Boehringer Ingelheim Gmbh 1-(M-alkanoyloxy-phenyl)-1-hydroxy-2-(N-lower alkyl-amino)-ethanes and salts thereof
LU71637A1 (en) * 1974-01-15 1975-06-17
US3957849A (en) * 1974-09-09 1976-05-18 Zoecon Corporation Cyclopropane esters
US4000315A (en) * 1974-09-09 1976-12-28 Zoecon Corporation Cyclopropane esters for the control of mites
ATE7689T1 (en) 1980-07-09 1984-06-15 Aktiebolaget Draco 1-(DIHYDROXYPHENYL)-2-AMINO-AETHANOL DERIVATIVES, PROCESSES AND MEANS FOR THEIR PREPARATION, AND AGENTS CONTAINING THESE DERIVATIVES.
DE3163114D1 (en) * 1980-07-09 1984-05-17 Draco Ab Therapeutically active derivatives of phenylethanol amines
FR2541999B1 (en) * 1983-03-04 1986-09-19 Bristol Myers Co PHENETHANOLAMINES AND THEIR USES
US4614830A (en) * 1985-08-09 1986-09-30 Sterling Drug Inc. Esterification process
IT1229846B (en) * 1989-04-20 1991-09-13 Simes ESTERS OF CATECOLAMINS.
US5118683A (en) * 1990-06-13 1992-06-02 Schering Corporation Esters of 4-hydroxy-1,3-benzenedimethanol and compositions and methods employing such compounds
US5011845A (en) * 1990-06-13 1991-04-30 Schering Corporation Cyclic diesters of 4-hydroxy-1,3-benzenedimethanol and compositions and methods employing such compounds
WO2010121022A1 (en) 2009-04-15 2010-10-21 Research Triangle Institute Monoamine reuptake inhibitors
ES2546492T3 (en) 2010-05-21 2015-09-24 Research Triangle Institute 1-Phenylmorpholine derivatives as hydroxybupropion analogs to treat drug dependence
ES2687095T3 (en) 2010-05-21 2018-10-23 Research Triangle Institute Phenylimorpholins and analogues thereof
WO2014108449A1 (en) 2013-01-08 2014-07-17 Atrogi Ab A screening method, a kit, a method of treatment and a compound for use in a method of treatment
CN108997261B (en) * 2017-06-07 2022-01-07 东莞市凯法生物医药有限公司 Compound and preparation method and application thereof
GB201714745D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714734D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714736D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714740D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB202205895D0 (en) 2022-04-22 2022-06-08 Atrogi Ab New medical uses
WO2024153813A1 (en) 2023-01-20 2024-07-25 Atrogi Ab Beta 2-adrenergic receptor agonists for treatment or prevention of muscle wasting
GB202302225D0 (en) 2023-02-16 2023-04-05 Atrogi Ab New medical uses
GB202303229D0 (en) 2023-03-06 2023-04-19 Atrogi Ab New medical uses

Also Published As

Publication number Publication date
NO129903B (en) 1974-06-10
IL42029A (en) 1974-01-14
ES378092A1 (en) 1973-01-01
JPS5314544B1 (en) 1978-05-18
CH522589A (en) 1972-06-30
FI54796C (en) 1979-03-12
FR2042295B1 (en) 1974-06-14
NL171155C (en) 1983-02-16
JPS5414096B1 (en) 1979-06-05
DK131459B (en) 1975-07-21
IE34583B1 (en) 1975-06-25
PH9407A (en) 1975-11-06
FR2042295A1 (en) 1971-02-12
NL171155B (en) 1982-09-16
DE2015573B2 (en) 1978-03-16
DE2015573C3 (en) 1978-11-02
BE748178A (en) 1970-09-28
IL34148A (en) 1974-01-14
DK131459C (en) 1975-12-08
DE2015573A1 (en) 1970-10-08
IL34148A0 (en) 1970-07-19
SE381039B (en) 1975-11-24
ZA702065B (en) 1971-01-27
AT300762B (en) 1972-08-10
FI54796B (en) 1978-11-30
NL7004671A (en) 1970-10-05
SE413503B (en) 1980-06-02
PH14377A (en) 1981-06-17
GB1298771A (en) 1972-12-06

Similar Documents

Publication Publication Date Title
IE34583L (en) Esters of hydroxyphenylalkanolamines
GB1456253A (en) Piperazine derivatives
GB1505305A (en) Benzcycloamide derivatives
JO1351B1 (en) Chemical compounds
IE41259L (en) Vincaminic acid esters
ES2072223A1 (en) Liposomes encapsulating doxorubicine.
ATE87313T1 (en) CEPHEM COMPOUNDS, PROCESSES FOR THEIR PRODUCTION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM.
GB1515241A (en) Beta-lactam antibiotics
GB1439724A (en) Berbine derivatives and pharmaceutical compositions containing them
GB1185522A (en) 00,5-(Iminomethano)-10,11-Dihydro-5H-Dibenzo [a,d]Cycloheptene and Derivatives
IE832273L (en) 7-substituted-3-vinyl-3-cephem compounds
IE780514L (en) Morphine derivatives
IE891578L (en) Compounds with central analgesic activity, process for their¹preparation and pharmaceutical compositions containing them
GB1352257A (en) Pyridyltriazoles their preparation and compositions containing them
IE812944L (en) Pyrazoline derivatives
EP0162924A4 (en) 5-fluorouracil derivatives and medicinal preparation containing same.
GB1530770A (en) 2,4-imidazolidinedione derivatives and preparation thereo
GB1160597A (en) Novel Isoxazolo[5,4-6]Pyridines and the Preparation Thereof
IE893258L (en) New 2-carbonyl substituted n,n&#39;-di-(trimethoxybenzoyl)¹piperazines, process for preparing the same and¹therapeutical compounds containing them
WO1986007537A3 (en) Pharmaceutical compositions containing azanaphthalenes
GB1531781A (en) N-propargyl-piperonylamine and its preparation and use
IE39401B1 (en) New adrenergic blocking aminopropanols
AU585981B2 (en) Benzo (IJ) quinolizine-2-carboxylic acid derivatives, the salts and their hydrates, pharmaceutical compositions thereof, and processes for preparing the same
IE790754L (en) Substituted ethanolamines
GB1468079A (en) Ethanolamine derivatives